Avenue Therapeutics ATXI
OTC ATXI
$0.38 -0.03 (-8.33%)
As of: Oct 23, 2026 · 9:30 AM EDT

Avenue Therapeutics (ATXI) Selling, General & Administrative (2016 - 2026)

Updated

Avenue Therapeutics (ATXI) reported Selling, General & Administrative of $460,000 for Q2 2026, down 49.7% from $915,000 a year earlier and down 10.5% from the prior quarter.

Analysis

Avenue Therapeutics (ATXI) Selling, General & Administrative (2016 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Avenue Therapeutics' Selling, General & Administrative came in at $2.22 million, down 48.0% year-over-year; for FY2025, it was $3.65 million, down 21.2% from FY2024.

  • Selling, General & Administrative has a five-year compound annual growth rate of 9.3% (FY2020 to FY2025).
  • By year, Selling, General & Administrative came in at $4.64 million in FY2024 (+11.0%), $4.18 million in FY2023 (-21.8%), $5.35 million in FY2022 (+115.2%) and $2.48 million in FY2021 (+5.8%).
  • The Q2 2026 figure ranks as the lowest quarterly Selling, General & Administrative since Q2 2022.
  • Year over year, Selling, General & Administrative has now declined in each of the last five quarters, with an average decline of 30.4% over the last eight quarters.
  • The high point for year-over-year Selling, General & Administrative in five years was Q4 2022 (growth of 542.6%); the low point was Q4 2023 (a decline of 66.2%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $514,000 (Q1 2026), $698,000 (Q4 2025) and $547,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 6.29 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 3.63 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 3.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 5.65 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.92 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 3.41 Bn
10 Avenue Therapeutics 1.32 Mn -9.61 Mn - 460,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 460,000.00
Mar 31, 2026 514,000.00
Dec 31, 2025 698,000.00
Sep 30, 2025 547,000.00
Jun 30, 2025 915,000.00
Mar 31, 2025 1.49 Mn
Dec 31, 2024 1.03 Mn
Sep 30, 2024 829,000.00
Jun 30, 2024 1.46 Mn
Mar 31, 2024 1.32 Mn
Dec 31, 2023 1.14 Mn
Sep 30, 2023 1.16 Mn
Jun 30, 2023 896,000.00
Mar 31, 2023 984,000.00
Dec 31, 2022 3.37 Mn
Sep 30, 2022 469,000.00
Jun 30, 2022 454,000.00
Mar 31, 2022 1.06 Mn
Dec 31, 2021 524,000.00
Sep 30, 2021 594,000.00
API Access

Avenue Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ATXI&period=max&api_key=YOUR_API_KEY